Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Third-Party Genetic Interpretation Tools: A Mixed-Methods Study of Consumer Motivation and Behavior.

Nelson SC, Bowen DJ, Fullerton SM.

Am J Hum Genet. 2019 Jul 3;105(1):122-131. doi: 10.1016/j.ajhg.2019.05.014. Epub 2019 Jun 13.

PMID:
31204012
2.

Ethics of inclusion: Cultivate trust in precision medicine.

Lee SS, Fullerton SM, Saperstein A, Shim JK.

Science. 2019 Jun 7;364(6444):941-942. doi: 10.1126/science.aaw8299. No abstract available.

PMID:
31171685
3.

The Genomic Medicine Integrative Research Framework: A Conceptual Framework for Conducting Genomic Medicine Research.

Horowitz CR, Orlando LA, Slavotinek AM, Peterson J, Angelo F, Biesecker B, Bonham VL, Cameron LD, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hindorff LA, Jarvik GP, Kaufman D, Kenny EE, Knight SJ, Koenig BA, Korf BR, Madden E, McGuire AL, Ou J, Wasserstein MP, Robinson M, Leventhal H, Sanderson SC.

Am J Hum Genet. 2019 Jun 6;104(6):1088-1096. doi: 10.1016/j.ajhg.2019.04.006. Epub 2019 May 16.

PMID:
31104772
4.

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Li M, Bennette CS, Amendola LM, Ragan Hart M, Heagerty P, Comstock B, Tarczy-Hornoch P, Fullerton SM, Regier DA, Burke W, Trinidad SB, Jarvik GP, Veenstra DL, Patrick DL.

J Genet Couns. 2019 Apr;28(2):477-490. doi: 10.1007/s10897-018-0286-9. Epub 2018 Dec 14.

PMID:
30964586
5.

You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.

Umeukeje EM, Young BA, Fullerton SM, Cavanaugh K, Owens D, Wilson JG, Burke W, Blacksher E.

J Am Soc Nephrol. 2019 Apr;30(4):526-530. doi: 10.1681/ASN.2018111091. Epub 2019 Mar 11. No abstract available.

PMID:
30858224
6.

"It would be so much easier": health system-led genetic risk notification-feasibility and acceptability of cascade screening in an integrated system.

Henrikson NB, Blasi PR, Fullerton SM, Grafton J, Leppig KA, Jarvik GP, Larson EB.

J Community Genet. 2019 Mar 6. doi: 10.1007/s12687-019-00412-z. [Epub ahead of print]

PMID:
30843145
7.

Practice Implications of Expanded Genetic Testing in Oncology.

Korngiebel DM, Zech JM, Chappelle A, Burke W, Carline JD, Gallagher TH, Fullerton SM.

Cancer Invest. 2019;37(1):39-45. doi: 10.1080/07357907.2018.1564926. Epub 2019 Jan 24.

PMID:
30676118
8.

The clinical imperative for inclusivity: Race, ethnicity, and ancestry (REA) in genomics.

Popejoy AB, Ritter DI, Crooks K, Currey E, Fullerton SM, Hindorff LA, Koenig B, Ramos EM, Sorokin EP, Wand H, Wright MW, Zou J, Gignoux CR, Bonham VL, Plon SE, Bustamante CD; Clinical Genome Resource (ClinGen) Ancestry and Diversity Working Group (ADWG).

Hum Mutat. 2018 Nov;39(11):1713-1720. doi: 10.1002/humu.23644.

PMID:
30311373
9.

Parents' attitudes toward consent and data sharing in biobanks: A multisite experimental survey.

Antommaria AHM, Brothers KB, Myers JA, Feygin YB, Aufox SA, Brilliant MH, Conway P, Fullerton SM, Garrison NA, Horowitz CR, Jarvik GP, Li R, Ludman EJ, McCarty CA, McCormick JB, Mercaldo ND, Myers MF, Sanderson SC, Shrubsole MJ, Schildcrout JS, Williams JL, Smith ME, Clayton EW, Holm IA.

AJOB Empir Bioeth. 2018 Jul-Sep;9(3):128-142. doi: 10.1080/23294515.2018.1505783. Epub 2018 Sep 21.

PMID:
30240342
10.

Cumulative Antidepressant Use and Risk of Dementia in a Prospective Cohort Study.

Heath L, Gray SL, Boudreau DM, Thummel K, Edwards KL, Fullerton SM, Crane PK, Larson EB.

J Am Geriatr Soc. 2018 Oct;66(10):1948-1955. doi: 10.1111/jgs.15508. Epub 2018 Sep 17.

PMID:
30221747
11.

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.

Amendola LM, Berg JS, Horowitz CR, Angelo F, Bensen JT, Biesecker BB, Biesecker LG, Cooper GM, East K, Filipski K, Fullerton SM, Gelb BD, Goddard KAB, Hailu B, Hart R, Hassmiller-Lich K, Joseph G, Kenny EE, Koenig BA, Knight S, Kwok PY, Lewis KL, McGuire AL, Norton ME, Ou J, Parsons DW, Powell BC, Risch N, Robinson M, Rini C, Scollon S, Slavotinek AM, Veenstra DL, Wasserstein MP, Wilfond BS, Hindorff LA; CSER consortium, Plon SE, Jarvik GP.

Am J Hum Genet. 2018 Sep 6;103(3):319-327. doi: 10.1016/j.ajhg.2018.08.007.

12.

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

Li M, Bennette CS, Amendola LM, Ragan Hart M, Heagerty P, Comstock B, Tarczy-Hornoch P, Fullerton SM, Regier DA, Burke W, Trinidad SB, Jarvik GP, Veenstra DL, Patrick DL.

J Genet Couns. 2018 Sep 1. doi: 10.1007/s10897-018-0286-9. [Epub ahead of print]

PMID:
30173308
13.

Informed Consent in Translational Genomics: Insufficient Without Trustworthy Governance.

Burke W, Beskow LM, Trinidad SB, Fullerton SM, Brelsford K.

J Law Med Ethics. 2018 Mar;46(1):79-86. doi: 10.1177/1073110518766023. Epub 2018 Mar 27. No abstract available.

14.

Hereditary cancer gene panel test reports: wide heterogeneity suggests need for standardization.

Makhnoon S, Shirts BH, Bowen DJ, Fullerton SM.

Genet Med. 2018 Nov;20(11):1438-1445. doi: 10.1038/gim.2018.23. Epub 2018 Mar 1.

PMID:
29493582
15.

"Bridge to the Literature"? Third-Party Genetic Interpretation Tools and the Views of Tool Developers.

Nelson SC, Fullerton SM.

J Genet Couns. 2018 Aug;27(4):770-781. doi: 10.1007/s10897-018-0217-9. Epub 2018 Feb 7.

PMID:
29411211
16.

Clinical verification of genetic results returned to research participants: findings from a Colon Cancer Family Registry.

Laurino MY, Truitt AR, Tenney L, Fisher D, Lindor NM, Veenstra D, Jarvik GP, Newcomb PA, Fullerton SM.

Mol Genet Genomic Med. 2017 Nov;5(6):700-708. doi: 10.1002/mgg3.328. Epub 2017 Aug 23.

17.

Clinical Genetic Testing for APOL1: Are we There Yet?

Young BA, Fullerton SM, Wilson JG, Cavanaugh K, Blacksher E, Spigner C, Himmelfarb J, Burke W.

Semin Nephrol. 2017 Nov;37(6):552-557. doi: 10.1016/j.semnephrol.2017.07.009. Review.

PMID:
29110763
18.

Discordance in selected designee for return of genomic findings in the event of participant death and estate executor.

Goodman JL, Amendola LM, Horike-Pyne M, Trinidad SB, Fullerton SM, Burke W, Jarvik GP.

Mol Genet Genomic Med. 2017 Jan 16;5(2):172-176. doi: 10.1002/mgg3.274. eCollection 2017 Mar.

19.

Public Attitudes toward Consent and Data Sharing in Biobank Research: A Large Multi-site Experimental Survey in the US.

Sanderson SC, Brothers KB, Mercaldo ND, Clayton EW, Antommaria AHM, Aufox SA, Brilliant MH, Campos D, Carrell DS, Connolly J, Conway P, Fullerton SM, Garrison NA, Horowitz CR, Jarvik GP, Kaufman D, Kitchner TE, Li R, Ludman EJ, McCarty CA, McCormick JB, McManus VD, Myers MF, Scrol A, Williams JL, Shrubsole MJ, Schildcrout JS, Smith ME, Holm IA.

Am J Hum Genet. 2017 Mar 2;100(3):414-427. doi: 10.1016/j.ajhg.2017.01.021. Epub 2017 Feb 9.

20.

No Panacea: Next-Gen Sequencing Will Not Mitigate Adoptees' Lack of Genetic Family Health History.

Fullerton SM.

Am J Bioeth. 2016 Dec;16(12):41-43. No abstract available.

21.

Conducting a large, multi-site survey about patients' views on broad consent: challenges and solutions.

Smith ME, Sanderson SC, Brothers KB, Myers MF, McCormick J, Aufox S, Shrubsole MJ, Garrison NA, Mercaldo ND, Schildcrout JS, Clayton EW, Antommaria AH, Basford M, Brilliant M, Connolly JJ, Fullerton SM, Horowitz CR, Jarvik GP, Kaufman D, Kitchner T, Li R, Ludman EJ, McCarty C, McManus V, Stallings S, Williams JL, Holm IA.

BMC Med Res Methodol. 2016 Nov 24;16(1):162.

22.

Patient safety in genomic medicine: an exploratory study.

Korngiebel DM, Fullerton SM, Burke W.

Genet Med. 2016 Nov;18(11):1136-1142. doi: 10.1038/gim.2016.16. Epub 2016 Mar 24.

23.

Genomics is failing on diversity.

Popejoy AB, Fullerton SM.

Nature. 2016 Oct 13;538(7624):161-164. doi: 10.1038/538161a. No abstract available.

24.

Allocation of Resources to Communication of Research Result Summaries.

Richards JE, Bane E, Fullerton SM, Ludman EJ, Jarvik G.

J Empir Res Hum Res Ethics. 2016 Oct;11(4):364-369. doi: 10.1177/1556264616667126. Epub 2016 Sep 19.

25.

Using Genetic Technologies To Reduce, Rather Than Widen, Health Disparities.

Smith CE, Fullerton SM, Dookeran KA, Hampel H, Tin A, Maruthur NM, Schisler JC, Henderson JA, Tucker KL, Ordovás JM.

Health Aff (Millwood). 2016 Aug 1;35(8):1367-73. doi: 10.1377/hlthaff.2015.1476. Review.

26.

Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.

Chalmers D, Nicol D, Kaye J, Bell J, Campbell AV, Ho CW, Kato K, Minari J, Ho CH, Mitchell C, Molnár-Gábor F, Otlowski M, Thiel D, Fullerton SM, Whitton T.

BMC Med Ethics. 2016 Jul 12;17(1):39. doi: 10.1186/s12910-016-0124-2. Review.

27.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Green RC, Goddard KA, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium.

Am J Hum Genet. 2016 Jul 7;99(1):246. doi: 10.1016/j.ajhg.2016.06.002. No abstract available.

28.

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.

Green RC, Goddard KAB, Jarvik GP, Amendola LM, Appelbaum PS, Berg JS, Bernhardt BA, Biesecker LG, Biswas S, Blout CL, Bowling KM, Brothers KB, Burke W, Caga-Anan CF, Chinnaiyan AM, Chung WK, Clayton EW, Cooper GM, East K, Evans JP, Fullerton SM, Garraway LA, Garrett JR, Gray SW, Henderson GE, Hindorff LA, Holm IA, Lewis MH, Hutter CM, Janne PA, Joffe S, Kaufman D, Knoppers BM, Koenig BA, Krantz ID, Manolio TA, McCullough L, McEwen J, McGuire A, Muzny D, Myers RM, Nickerson DA, Ou J, Parsons DW, Petersen GM, Plon SE, Rehm HL, Roberts JS, Robinson D, Salama JS, Scollon S, Sharp RR, Shirts B, Spinner NB, Tabor HK, Tarczy-Hornoch P, Veenstra DL, Wagle N, Weck K, Wilfond BS, Wilhelmsen K, Wolf SM, Wynn J, Yu JH; CSER Consortium.

Am J Hum Genet. 2016 Jun 2;98(6):1051-1066. doi: 10.1016/j.ajhg.2016.04.011. Epub 2016 May 12. Erratum in: Am J Hum Genet. 2016 Jul 7;99(1):246.

29.

Engaging Study Participants in Research Dissemination at a Center for Population Health and Health Disparities.

Knerr S, Hohl SD, Molina Y, Neuhouser ML, Li CI, Coronado GD, Fullerton SM, Thompson B.

Prog Community Health Partnersh. 2016;10(4):569-576. doi: 10.1353/cpr.2016.0065.

30.

Patients' Choices for Return of Exome Sequencing Results to Relatives in the Event of Their Death.

Amendola LM, Horike-Pyne M, Trinidad SB, Fullerton SM, Evans BJ, Burke W, Jarvik GP.

J Law Med Ethics. 2015 Fall;43(3):476-85. doi: 10.1111/jlme.12290.

31.

Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network.

Gallego CJ, Burt A, Sundaresan AS, Ye Z, Shaw C, Crosslin DR, Crane PK, Fullerton SM, Hansen K, Carrell D, Kuivaniemi H, Derr K, de Andrade M, McCarty CA, Kitchner TE, Ragon BK, Stallings SC, Papa G, Bochenek J, Smith ME, Aufox SA, Pacheco JA, Patel V, Friesema EM, Erwin AL, Gottesman O, Gerhard GS, Ritchie M, Motulsky AG, Kullo IJ, Larson EB, Tromp G, Brilliant MH, Bottinger E, Denny JC, Roden DM, Williams MS, Jarvik GP.

Am J Hum Genet. 2015 Oct 1;97(4):512-20. doi: 10.1016/j.ajhg.2015.08.008. Epub 2015 Sep 10.

32.

Broad Consent for Research With Biological Samples: Workshop Conclusions.

Grady C, Eckstein L, Berkman B, Brock D, Cook-Deegan R, Fullerton SM, Greely H, Hansson MG, Hull S, Kim S, Lo B, Pentz R, Rodriguez L, Weil C, Wilfond BS, Wendler D.

Am J Bioeth. 2015;15(9):34-42. doi: 10.1080/15265161.2015.1062162.

33.

Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network.

Crosslin DR, Robertson PD, Carrell DS, Gordon AS, Hanna DS, Burt A, Fullerton SM, Scrol A, Ralston J, Leppig K, Hartzler A, Baldwin E, Andrade Md, Kullo IJ, Tromp G, Doheny KF, Ritchie MD, Crane PK, Nickerson DA, Larson EB, Jarvik GP.

Genome Med. 2015 Jul 3;7(1):67. doi: 10.1186/s13073-015-0181-z. eCollection 2015.

34.

Looking for Trouble and Finding It.

Trinidad SB, Fullerton SM, Burke W.

Am J Bioeth. 2015;15(7):15-7. doi: 10.1080/15265161.2015.1039731. No abstract available.

35.

Rural Mexican-Americans' perceptions of family health history, genetics, and disease risk: implications for disparities-focused research dissemination.

Malen R, Knerr S, Delgado F, Fullerton SM, Thompson B.

J Community Genet. 2016 Jan;7(1):91-6. doi: 10.1007/s12687-015-0245-1. Epub 2015 Jul 4.

36.

"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing.

Trinidad SB, Coffin TB, Fullerton SM, Ralston J, Jarvik GP, Larson EB.

Perm J. 2015 Summer;19(3):21-7. doi: 10.7812/TPP/15-046. Epub 2015 Jun 1.

37.

Awareness of Federal Regulatory Mechanisms Relevant to Community-Engaged Research: Survey of Health Disparities-Oriented NIH-Funded Investigators.

Fullerton SM, Anderson EE, Cowan K, Malen RC, Brugge D.

J Empir Res Hum Res Ethics. 2015 Feb;10(1):13-21. doi: 10.1177/1556264614561964. Epub 2014 Dec 10.

38.

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.

Amendola LM, Dorschner MO, Robertson PD, Salama JS, Hart R, Shirts BH, Murray ML, Tokita MJ, Gallego CJ, Kim DS, Bennett JT, Crosslin DR, Ranchalis J, Jones KL, Rosenthal EA, Jarvik ER, Itsara A, Turner EH, Herman DS, Schleit J, Burt A, Jamal SM, Abrudan JL, Johnson AD, Conlin LK, Dulik MC, Santani A, Metterville DR, Kelly M, Foreman AK, Lee K, Taylor KD, Guo X, Crooks K, Kiedrowski LA, Raffel LJ, Gordon O, Machini K, Desnick RJ, Biesecker LG, Lubitz SA, Mulchandani S, Cooper GM, Joffe S, Richards CS, Yang Y, Rotter JI, Rich SS, O'Donnell CJ, Berg JS, Spinner NB, Evans JP, Fullerton SM, Leppig KA, Bennett RL, Bird T, Sybert VP, Grady WM, Tabor HK, Kim JH, Bamshad MJ, Wilfond B, Motulsky AG, Scott CR, Pritchard CC, Walsh TD, Burke W, Raskind WH, Byers P, Hisama FM, Rehm H, Nickerson DA, Jarvik GP.

Genome Res. 2015 Mar;25(3):305-15. doi: 10.1101/gr.183483.114. Epub 2015 Jan 30.

39.

Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromes.

Gallego CJ, Bennette CS, Heagerty P, Comstock B, Horike-Pyne M, Hisama F, Amendola LM, Bennett RL, Dorschner MO, Tarczy-Hornoch P, Grady WM, Fullerton SM, Trinidad SB, Regier DA, Nickerson DA, Burke W, Patrick DL, Jarvik GP, Veenstra DL.

Contemp Clin Trials. 2014 Sep;39(1):1-8. doi: 10.1016/j.cct.2014.06.016. Epub 2014 Jul 3.

40.

Return of genomic results to research participants: the floor, the ceiling, and the choices in between.

Jarvik GP, Amendola LM, Berg JS, Brothers K, Clayton EW, Chung W, Evans BJ, Evans JP, Fullerton SM, Gallego CJ, Garrison NA, Gray SW, Holm IA, Kullo IJ, Lehmann LS, McCarty C, Prows CA, Rehm HL, Sharp RR, Salama J, Sanderson S, Van Driest SL, Williams MS, Wolf SM, Wolf WA; eMERGE Act-ROR Committee and CERC Committee; CSER Act-ROR Working Group, Burke W.

Am J Hum Genet. 2014 Jun 5;94(6):818-26. doi: 10.1016/j.ajhg.2014.04.009. Epub 2014 May 8.

41.

Refining the structure and content of clinical genomic reports.

Dorschner MO, Amendola LM, Shirts BH, Kiedrowski L, Salama J, Gordon AS, Fullerton SM, Tarczy-Hornoch P, Byers PH, Jarvik GP.

Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):85-92. doi: 10.1002/ajmg.c.31395. Epub 2014 Mar 10.

42.

A review of the key issues associated with the commercialization of biobanks.

Caulfield T, Burningham S, Joly Y, Master Z, Shabani M, Borry P, Becker A, Burgess M, Calder K, Critchley C, Edwards K, Fullerton SM, Gottweis H, Hyde-Lay R, Illes J, Isasi R, Kato K, Kaye J, Knoppers B, Lynch J, McGuire A, Meslin E, Nicol D, O'Doherty K, Ogbogu U, Otlowski M, Pullman D, Ries N, Scott C, Sears M, Wallace H, Zawati MH.

J Law Biosci. 2014 Feb 25;1(1):94-110. eCollection 2014 Mar. No abstract available.

43.

Returning pleiotropic results from genetic testing to patients and research participants.

Kocarnik JM, Fullerton SM.

JAMA. 2014 Feb 26;311(8):795-6. doi: 10.1001/jama.2014.369. No abstract available.

44.

Stakeholder engagement: a key component of integrating genomic information into electronic health records.

Hartzler A, McCarty CA, Rasmussen LV, Williams MS, Brilliant M, Bowton EA, Clayton EW, Faucett WA, Ferryman K, Field JR, Fullerton SM, Horowitz CR, Koenig BA, McCormick JB, Ralston JD, Sanderson SC, Smith ME, Trinidad SB.

Genet Med. 2013 Oct;15(10):792-801. doi: 10.1038/gim.2013.127. Epub 2013 Sep 12. Review.

45.

Forensic familial searching: scientific and social implications.

Garrison NA, Rohlfs RV, Fullerton SM.

Nat Rev Genet. 2013 Jul;14(7):445. No abstract available.

46.

Using genetically informed, randomized prevention trials to test etiological hypotheses about child and adolescent drug use and psychopathology.

Brody GH, Beach SR, Hill KG, Howe GW, Prado G, Fullerton SM.

Am J Public Health. 2013 Oct;103 Suppl 1:S19-24. doi: 10.2105/AJPH.2012.301080. Epub 2013 Aug 8.

47.

Return of incidental findings in genomic medicine: measuring what patients value--development of an instrument to measure preferences for information from next-generation testing (IMPRINT).

Bennette CS, Trinidad SB, Fullerton SM, Patrick D, Amendola L, Burke W, Hisama FM, Jarvik GP, Regier DA, Veenstra DL.

Genet Med. 2013 Nov;15(11):873-81. doi: 10.1038/gim.2013.63. Epub 2013 May 30.

48.

Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?

Trinidad SB, Fullerton SM, Bares JM, Jarvik GP, Larson EB, Burke W.

AJOB Prim Res. 2012 Jul 1;3(3):3-11. Epub 2012 Jun 19.

49.

Values in translation: how asking the right questions can move translational science toward greater health impact.

Kelley M, Edwards K, Starks H, Fullerton SM, James R, Goering S, Holland S, Disis ML, Burke W.

Clin Transl Sci. 2012 Dec;5(6):445-51. doi: 10.1111/j.1752-8062.2012.00441.x. Epub 2012 Aug 7. Review.

Supplemental Content

Loading ...
Support Center